30th Apr 2024 A plain language summary of the PRIMA/ENGOT-OV26/GOG-3012 study: niraparib maintenance treatment in patients with newly diagnosed ovarian cancer
25th Jan 2024 The PRIMA study: a plain language summary on the efficacy and safety of individualized niraparib dosing based on body weight and platelet count